Antibody Drug Conjugates Transforming Targeted Cancer Therapies and Clinical Outcomes
"Global Demand Outlook for Executive Summary Global Antibody Drug Conjugates Market Size and Share Introduction
Antibody Drug Conjugates (ADCs) are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Often described as ""biological missiles,"" ADCs consist of a monoclonal antibody chemically linked to a potent cell-killing drug. Unlike traditional...
0 Yorum
0 Paylar
English